Cefixime Patent Expiration

Cefixime is Used for treating bacterial infections. It was first introduced by Lederle Laboratories Div American Cyanamid Co in its drug Suprax on Apr 28, 1989. 8 different companies have introduced drugs containing Cefixime.


Cefixime Patents

Given below is the list of patents protecting Cefixime, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Suprax US9233112 Pharmaceutical compositions of cefixime Dec 14, 2028 Lupin Ltd



Cefixime's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Cefixime Generic API Manufacturers

Several generic applications have been filed for Cefixime. The first generic version for Cefixime was by Lupin Pharmaceuticals Inc and was approved on Feb 12, 2004. And the latest generic version is by Fdc Ltd and was approved on Dec 17, 2024.

Given below is the list of companies who have filed for Cefixime generic, along with the locations of their manufacturing plants worldwide.